Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

This study has been terminated.
(Extreme toxicity)
Information provided by (Responsible Party):
Afshin Dowlati, MD, Case Comprehensive Cancer Center Identifier:
First received: July 31, 2008
Last updated: April 17, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)